Quest Diagnostics (NYSE:DGX) Is Increasing Its Dividend To $0.71
The board of Quest Diagnostics Incorporated (NYSE:DGX) has announced that it will be paying its dividend of $0.71 on the 24th of April, an increased payment from last year's comparable dividend. This makes the dividend yield 2.0%, which is above the industry average.
View our latest analysis for Quest Diagnostics
Quest Diagnostics' Earnings Easily Cover The Distributions
While it is great to have a strong dividend yield, we should also consider whether the payment is sustainable. Before making this announcement, Quest Diagnostics was easily earning enough to cover the dividend. This means that most of its earnings are being retained to grow the business.
The next year is set to see EPS grow by 13.1%. Assuming the dividend continues along recent trends, we think the payout ratio could be 30% by next year, which is in a pretty sustainable range.
Quest Diagnostics Has A Solid Track Record
The company has an extended history of paying stable dividends. Since 2013, the annual payment back then was $0.68, compared to the most recent full-year payment of $2.84. This works out to be a compound annual growth rate (CAGR) of approximately 15% a year over that time. So, dividends have been growing pretty quickly, and even more impressively, they haven't experienced any notable falls during this period.
We Could See Quest Diagnostics' Dividend Growing
The company's investors will be pleased to have been receiving dividend income for some time. It's encouraging to see that Quest Diagnostics has been growing its earnings per share at 8.6% a year over the past five years. Quest Diagnostics definitely has the potential to grow its dividend in the future with earnings on an uptrend and a low payout ratio.
Quest Diagnostics Looks Like A Great Dividend Stock
Overall, we think this could be an attractive income stock, and it is only getting better by paying a higher dividend this year. Distributions are quite easily covered by earnings, which are also being converted to cash flows. Taking this all into consideration, this looks like it could be a good dividend opportunity.
Investors generally tend to favour companies with a consistent, stable dividend policy as opposed to those operating an irregular one. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. For example, we've picked out 2 warning signs for Quest Diagnostics that investors should know about before committing capital to this stock. Is Quest Diagnostics not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
